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Executive Summary
As America considers ways to reform its health care system, a central focus must be the fact that women 
need and use the health care system more than men. Women’s reproductive health care needs are part 
of the reason for increased use, but more women than men also suffer from one or more chronic 
conditions that require ongoing care, such as diabetes, depression, heart disease, and osteoporosis. 
Earlier this year, the Mailman School of Public Health at Columbia University released a report,
Women’s Health and Health Care Reform: The Key Role of Comprehensive Reproductive Health Care. 
That study makes a scientific, data-driven case for a comprehensive standard of health for American 
women— affordable and stable coverage that enables women to attain good health in childhood and 
adolescence, maintain good health during their reproductive years, and age well. The report also calls 
for significant preventive and public health investment. The report’s recommendations have been en-
dorsed by 38 of the nation’s 50 Deans of Schools of Public Health. 
Our report, a companion to the Columbia report, was prepared by the Jacobs Institute of Women’s 
Health at The George Washington University School of Public Health and Health Services, and made 
possible by the Women Donors Network and the Communications Consortium Media Center. It 
underscores the key roles of both preventive care and continuity of care for women across the lifespan, 
including primary and specialty care as well as pregnancy care. Further, this report demonstrates that 
providing continuity of care for women’s health would not only result in better health for women, but 
also may yield cost savings for the U.S. health care system as a whole. 
We estimate the direct and indirect costs of care for women for the major chronic diseases and 
conditions that women face across the lifespan. We also identify the key primary care and preventive 
services that can lead to prevention, early detection or early intervention for these conditions.  
Health care screening, counseling, early diagnosis, and early intervention health care services are im-
portant for women at each stage of their lives. But women typically seek care in primary care settings for 
family planning services and cancer screening prior to becoming pregnant. As a result, high quality care 
during the reproductive years offers an important opportunity to identify risk factors and health 
conditions and to provide appropriate interventions and quality care.
 
Primary and preventive care standards also underscore that screening for cancer, risks for heart disease, 
family planning services and detection of violence, as well as smoking cessation and nutrition 
counseling, should begin during the reproductive years. A healthy pregnancy, leading to the best 
outcome for both mother and child, begins when the woman is in the best possible health prior to 
conception. Counseling on obesity prevention and smoking cessation are vital prior to pregnancy; 
delaying counseling until after conception compromises a woman’s ability to achieve the best outcomes. 
Identification of hypertension and/or gestational diabetes in pregnancy provides an opportunity to 
identify women at higher risk of heart disease and diabetes later in life.
Women’s Health and Health Care Reform 4
Early care is particularly important for women who are members of racial and ethnic minority groups. 
Approximately one in every three residents of the United States self-identifies as African-American, 
American Indian/Alaska Native, Asian/Pacific-American, or Latino. Disparities in health status are closely 
associated with race and ethnicity – in health insurance coverage, psychosocial stress, discrimination 
and health care access and quality, and in deaths due to breast cancer and pregnancy-related causes. 
Our analysis shows that in 2009: 
	The direct costs of cardiovascular disease, which affects 43 million U.S. women, are estimated at   
$162 billion a year.  
	Direct and indirect costs of depression for both women and men are estimated at over $100 
billion, with direct medical costs for depression in women alone estimated to be over $20 billion. 
	The direct medical costs alone of osteoporosis, which affects nearly 8 million women, are 
estimated at nearly $14 billion.  
	The direct costs of diabetes in women are estimated at over $58 billion.
	The direct costs of breast cancer are estimated at $9.1 billion.
	The Centers for Medicare and Medicaid Services (CMS), which pays a portion of these direct   
medical costs for women over 65 and disabled women, reports that for women alone it    
will spend $33.7 billion for cardiovascular disease, $4.4 billion for depression, $4.8 billion for   
diabetes, and over $0.8 billion for mammography in FY 2009.  
Important primary and preventive services for women include screening for cancer, risks for heart 
disease and diabetes, sexually transmitted infections, intimate partner violence, provision of family 
planning services as well as counseling and interventions to reduce smoking or alcohol use/abuse, and 
improved nutrition and fitness are critical to achieve high quality care for women. These primary and
preventive services during the reproductive years provide the opportunity to reduce the impact of 
chronic illness later in life through prevention, early detection and early intervention.
   
The evidence presented in these findings reinforces the link between health reform and reducing the 
economic burden of chronic disease through primary and preventive care that can prevent or mitigate 
the effects of disease. Of particular importance are:  
	Comprehensive primary care and reproductive health care – and access to early prevention, 
detection and appropriate treatment – is available to all women; 
	Health care for pregnant women begins prior to pregnancy, including help with the timing and 
spacing of pregnancies; and 
	Women’s health care is comprehensive and continuous across the lifespan. 
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Introduction 
Over the course of women’s lives, due in part to their reproductive health needs, women use the health 
care system more than men (Patchias and Waxman, 2007). Women suffer from chronic disease and 
disability at a rate disproportionate to men, with consequences for their own health and the health 
of their families. More women than men (38% vs. 30%) suffer from one or more chronic conditions, 
such as diabetes, asthma or hypertension, which require ongoing coordinated care. A large proportion 
of elderly women suffer from arthritis and hypertension, 61% and 58% respectively (Kaiser Family 
Foundation, 2005). Women of color have poorer health outcomes for many health conditions, and 
eliminating health disparities is a major public health challenge.
Approximately two-thirds of women obtain their health insurance through employer-based coverage 
(either from their employer or their spouses’ employer) (Glied et al., 2008). In 2008, 6% of women 
purchased private individual health insurance, 10% were covered by Medicaid, and 3% were covered 
by other government insurance (Kaiser, 2008). Women with insurance often face higher premiums 
(National Women’s Law Center, 2009) and spend more on out-of-pocket costs (Rustgi, Doty, Collins, 
2000) than men. Overall, 18% of women under 65 are uninsured (Kaiser, 2008). Uninsured people are 
less likely to receive medical care and are more likely to be in poorer health than those who are insured 
(Hadley, 2007). Stable and continuous health care coverage of the range of primary and preventive 
health services for women should be an essential element of health care reform. 
Earlier this year, the Mailman School of Public Health at Columbia University released a report, 
Women’s Health and Health Care Reform: The Role of Comprehensive Reproductive Health Care. 
That study makes a scientific, data-driven case for a comprehensive standard of health for American 
women—a standard that enables women to attain good health in childhood and adolescence, maintain 
good health during their reproductive years, and age well. (Chavkin, Rosenbaum, et al., 2009). The 
Columbia report’s findings have been endorsed by 39 of the nation’s 50 Deans of Schools of Public 
Health. 
The following report was prepared by the Jacobs Institute of Women’s Health at The George Washington 
University School of Public Health and Health Services, and made possible by funding from the Women 
Donors Network and the Communications Consortium Media Center. It examines the costs of health 
care for women across the lifespan, and the role of primary and specialty care, as well as pregnancy 
care.  This report identifies the prevalence, major health disparities, costs of care, and the available 
preventive services in health care settings for women.
We outline the economic underpinnings of disease and chronic conditions and the economic costs to 
the health care system and to the U.S. economy of chronic illness in women. Prevention, early detection 
and early intervention through primary care and pregnancy care before, during, and after women’s 
reproductive years are essential to the strategy to reduce the burden of illness and disability. 
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Women typically seek care in primary care settings for family planning services and cancer screening 
prior to becoming pregnant (Hauenstein et al., 2006). Risk factors and health conditions can be 
identified during these visits to provide interventions that can reduce the cost of care later in life. 
Screening for cancer, identification of risks for heart disease, provision of family planning services and 
early detection of violence, as well as smoking cessation and nutrition counseling, begins during the 
reproductive years.  
Although not all preventive health care services have been shown to result in immediate direct or 
indirect cost savings, prevention, early detection, and early appropriate care are critical to reduce the 
impact of illness in women across the lifespan. Comprehensive health care services, delivered through 
primary care settings, specialty care and during pregnancy, can reduce the incidence and burden of 
chronic illness later in life.  
Six of the leading causes of death among women are associated with behavioral risks; thus screening, 
counseling and other interventions are key to improving health outcomes. Table 1 lists the prevalence of 
chronic disease and conditions in women and major risk factors. Tobacco smoking, poor diet, physical 
inactivity, and alcohol abuse are responsible for an estimated 900,000 deaths annually, or 40% of 
total yearly mortality. One in four women is obese and one in six women continues to smoke (Table 
1). Studies suggest substantial health care savings may be achieved by investing in health promotion 
programs that modify poor health habits. In particular, physical inactivity and smoking are significant 
predictors of higher medical costs (Bland et al., 2009). 
A healthy pregnancy, leading to the best outcome for both mother and child, begins when a woman is 
in the best possible health prior to conception. Counseling on obesity prevention and smoking cessation 
are vital prior to pregnancy; delaying counseling until after conception compromises a woman’s ability 
to achieve the best outcomes. Women should receive timely screening services during pregnancy 
for conditions such as gestational diabetes, hypertension, and risks of preterm birth, depression, and 
violence. Unfortunately, pregnancy care is often not covered by individual insurance policies, and 
many women may be left to piece together haphazard contraceptive, pregnancy care and other benefits 
throughout their reproductive years (Kaiser Family Foundation, 2007; Neuschler, 2004; National 
Women’s Law Center, 2009).
Approximately one in every three residents of the United States self-identifies as African-American, 
American Indian/Alaska Native, Asian/Pacific-American, or Latino. A large and growing body of research 
indicates that race and ethnicity continue to matter in access to, quality of, and delivery of care. Race 
is associated with disparities in health status, health insurance coverage, psychosocial stress and 
discrimination. People of color consistently fare poorer on many health outcomes, including deaths due 
to breast cancer and pregnancy-related causes. 
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Table 1 : Prevalence of Chronic Disease among Women
 
Prevalence 





CVD (including hypertension) 38.5 42.0




Breast Cancer 2.1 2.5
Lung Cancerc 0.1 0.1
Cervical Cancer 0.9 1.1
Intimate Partner Violence 
(lifetime)d 26.4 30.2
Intimate Partner Violence 2.2 2.5
Source: NHIS 2007, with the exception of NHANES (2003-2006) 
for hypertension, (1999-2004) CVD, and (1988-1994) COPD, NHIS 
2007 calculated by CDC for psychological distress, America's Bone 
Health, National Osteoporosis Foundation (2002) for osteoporosis, 
BRFSS 2005 for IPV, and 2005 United States Cancer Statistics for 
Lung cancer.  
a) The age group for obesity (20+) and osteoporosis (50+).  
b) COPD includes both moderate obstructive lung disease (both 
the FEV1/FVC ratio was <70% and the FEV1 was <80% of the 
predicted value) and mild obstructive lung disease (FEV1/FVC ratio 
was <70% and the FEV1 was >80% of the predicted value). 
c) 2005 incidence.   
d) Lifetime prevalence of IPV (definition see the IPV section).
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Methods
Economic burden (or cost of illness) studies provide a consistent method of evaluation which can 
facilitate insight into the economic impact that illness has on society as a whole, as well as on 
individuals and their families. Costs of illness can be divided into direct costs associated with medical 
needs (e.g., inpatient stays, outpatient visits, and drugs) and indirect costs related to the inability to work 
and reduced productivity.
For this report, we rely on secondary data sources from nationally representative surveys. Our main 
source for prevalence estimates is the 2007 National Health Interview Survey (NHIS), one of the major 
data collection programs of the National Center for Health Statistics (NCHS) at the Centers for Disease 
Control and Prevention (CDC). The NHIS data are widely used by the Department of Health and Human 
Services (HHS) to monitor trends in health and health care, and to track progress toward achieving 
national health objectives. NHIS 2007 was used for smoking, obesity, diabetes, COPD, breast cancer, 
and cervical cancer. For psychological distress we used CDC estimates that are based on the 2007 NHIS.
The National Health and Nutrition Examination Survey (NHANES) examines a nationally representative 
sample of about 5,000 persons each year. The combination of personal interviews and physical 
examinations makes NHANES unique and its health estimates more reliable. In this paper we report 
CDC estimates for hypertension that are based on the NHANES 2003-2006 data (NCHS, 2009); National 
Heart Lung and Blood Institute estimates for CVD based on NHANES 1999-2004 (NHLBI, 2007); 
National Osteoporosis Foundation estimates for osteoporosis based on NHANES III (HHS, 2004); and 
CDC estimates for COPD that are based on the NHANES 1988-1994 data (CDC, 2002). CDC reported 
estimates from the United States Cancer Statistics (USCS) database are used for lung cancer incidence. 
Reported IPV estimates are estimated by Breiding, Black, Ryan (2008) on the basis of Behavioral Risk 
Factor Surveillance System (BRFSS) data from 16 states. Where possible we rely on crude prevalence 
estimates. All sources with the exception of the NHIS 2007 data are crude (non-age adjusted) estimates. 
Estimates of the total number of women suffering from chronic disease were calculated on the basis 
of the prevalence estimates and census data available online (U.S. Census Bureau). We note that 
the calculation of total number of women based on age-adjusted prevalence estimates is imperfect. 
However, the difference between age-adjusted prevalence and crude prevalence does not bias the 
numbers that significantly and therefore the total numbers give a correct estimate of the order of 
magnitude of disease prevalence. 
A search of English-language articles was conducted on PubMed using a combination of the following 
keywords: economic burden of disease, cost-of-illness, chronic diseases, and the specific diseases we 
examined. We limited the literature cited in this study to analyses that measure both direct and indirect 
costs where possible and were published after 1995. In addition, researchers with expertise in the field 
of economic burden of disease issues were consulted regarding existing publications and works in 
progress.
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We report direct medical costs as they relate to women on the basis of the original cost estimates 
(smoking, osteoporosis, cervical cancer, and IPV). Direct medical costs were calculated where gender 
specific cost estimations were missing using the share of the disease burden on women (obesity, CVD, 
depression, diabetes, COPD, and HIV/AIDS). In the case of overall mental disorders and sexually 
transmittable infections no reliable burden of disease was available considering for these specific disease 
groups there is no clear gender differentiation in prevalence (Kessler et al., 2005). Therefore, we feel that 
a reasonable, rough estimate can be produced by dividing the total economic burden of disease in half 
to represent the economic burden of disease on women. 
Most of the papers we reviewed provide gender-specific indirect costs (with the exclusion of 
osteoporosis, cervical cancer, and intimate partner violence). Methods and inclusion criteria used across 
research and disease groups vary widely, which negatively affects the comparability of the estimates. 
Therefore, female-specific indirect cost estimates were not reported. To allow comparability of cost 
estimates all costs throughout this document have been converted to current 2009 dollars. A complete 
list with references is made available in the Appendix.
Spending on women’s health services by Medicare and Medicaid are reported from the Moyer Table 
on Women’s Health 2009, provided by the Centers for Medicare and Medicaid Services and the 
Department of Health and Human Services to Congress (available from HHS). 
The recommended preventive screening and counseling services for women are based on the 
recommendations made by the United States Preventive Services Task Force and the Department of 
Health and Human Services Office on Women’s Health, the CDC and health professional organizations.
  
Women’s Health and Health Care Reform 10
Findings
Direct and indirect costs of the major chronic health conditions faced by women (cardiovascular 
disease, mental health disorders, breast cancer, cervical cancer, diabetes, osteoporosis, intimate partner 
violence, sexually transmitted infections, HIV/AIDS), as well as for health-related behaviors (smoking 
and obesity) (Table 2) have been estimated. Cost estimates are available for direct and indirect costs for 
both men and women in many cases, and we have estimated the direct costs for women only where 
possible. Table 2 demonstrates that cardiovascular disease, which affects 43 million U.S. women, 
is estimated to cost $166.4 billion per year in direct costs. Depression for both women and men is 
estimated to cost over $100 billion in direct and indirect costs, and over $20 billion in direct costs 
for women. Osteoporosis, which affects nearly 8 million women, costs nearly $14 billion for direct 
medical costs alone. Direct costs for breast cancer care are estimated to be $9.1 billion. The Centers for 
Medicare and Medicaid Services (CMS) pays a portion of these direct medical costs for women over 65 
and women with disabilities; CMS reports that it will spend $33.7 billion for cardiovascular disease in 
women, $4.4 billion for depression in women and $ 0.8 billion for mammography in FY 2009. 
We also analyzed the need for timely preventive care, health care screening, early detection, treatment 
and counseling, which are important throughout the lifespan as well as prior to and during pregnancy. 
Health disparities in outcomes are also identified. Figure 1 illustrates the range of health care screening, 
counseling and early intervention health care services that are important for women at each stage of 
their lives.
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Table 2: Economic Burden of Disease for Men and Women (Billions of U.S. Dollars, 2009)








Smokingb 96.6 104.3 200.9 46.1g --
Obesityc 114.1 -- -- 57.1g --
CVDd 313.8 161.5 475.3 162.0g 33.7
Depression 32.0 70.2 102.3 20.2 4.4
Mental Disorderse 169.5 39.7 209.2 84.7g,h 4.4
Diabetes 118.7 59.4 178.1 58.2g 4.8
Osteoporosis 18.4 -- -- 13.9 --
COPD 23.7 18.5 42.2 9.6g 5.1
Breast Cancer 9.1 -- -- 9.1 0.8i
Cervical Cancer -- -- -- 0.34-0.45 --
IPV -- -- -- 4.7 --
STIs (excluding HIV) 0.1 -- -- 0.04h --
HIV/AIDS 0.1 -- -- 0.02 --
-- Data not available.
a) References for economic burden of disease can be found in the main document.  
b) Economic costs of smoking include a share of CVD, diabetes, and COPD costs. 
c) Economic costs of obesity include a share CVD and diabetes costs.  
d) CVD includes heart diseases, hypertensive disease, stroke, and heart failure. 
e) Mental Disorders includes depression.  
f) Source: Department of Health and Human Services: Women’s Health Moyer Table (2009).  
g) Direct costs are estimated using the share of women who suffer from the condition (or health behavior). 
h) Due to the lack of gender specific prevalence data this estimate is calculated on the basis of 50% share 
of burden of disease for women.  
i) CMS estimated benefit outlays for screening and diagnostic mammograms.
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          Figure 1: Recommended Preventive Screening and Counseling Services for Women
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Source: United States Preventive Services Task Force 
(http://www.ahrq.gov/clinic/pocketgd08/pocketgd08.pdf), HHS, Office of Women’s Health 
(http://www.womenshealth.gov/screeningcharts/general/general.pdf), and CDC (2006b).
* Counseling 
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Chronic Diseases and Conditions:
 
Cardiovascular Disease  
Prevalence: Cardiovascular disease (CVD)1 is the most prevalent of the chronic diseases affecting 
both women and men; almost four out of every 10 adult women over age 18 suffers from it (Table 
1). Cardiovascular disease also causes a large share of mortality: over one-third of deaths in 2004. 
Prevalence of CVD increases with age (NHANES 1999-2004): 51% of women over age 50 suffer 
from hypertension (Robinson, 2007). CVD patients also have an increased risk of co-morbidities. 
Hypertensive disorders complicate an estimated 12% to 22% of all pregnancies and are responsible for 
17.6% of maternal deaths in the United States (Walker, 2000; Koonin et al., 1997).  
Health disparities: African-American women are more likely to have high blood pressure: 42% of 
African-American women over age 20 suffer from hypertension, in contrast to 27% of whites and 24% 
of Mexican-American women (NHANES 2004-2005). African-American women are more likely to die 
from heart disease and stroke than white women. In 2005, age-adjusted death rates for heart disease and 
stroke are respectively 28% and 38% higher among African Americans than among whites (AHA, 2009). 
A 2007 series of analyses of NCQA HEDIS managed care plan data revealed that compared to men, 
women are less likely to be screened for common CVD risk factors (e.g., hypertension, dyslipidemia, 
blood glucose levels), and that African-American women experienced even greater screening disparities 
(Chou et al., 2007).
Costs: Total costs associated with CVD2 are the highest among all the disease groups identified (Table 1). 
Economic costs (direct and indirect costs) for men and women will comprise an estimated $475 billion 
in 2009 (AHA, 2009). In 2009, total economic costs for cardiac heart disease are estimated to be $165.4 
billion, of which $121.6 billion will be for indirect costs and total economic costs for hypertensive 
disease at $73.4 billion, of which $19.2 billion are estimated as indirect costs (AHA, 2009). Compared 
with adults without hypertension, the annual additional direct costs for treating hypertension were 
estimated at $1,131 per hypertension patient (Balu and Thomas, 2006). Of these additional direct costs, 
more than 90% are attributed to prescription medicines, inpatient visits and outpatient visits (Balu and 
Thomas, 2006). Based on the proportion of women with CVD (52% in 2006), direct costs associated 
with CVD for women would be $162 billion. These figures are more likely underestimated rather than 
overestimated. Balu and Thomas (2006) found that treatment costs for hypertension increase with age 
and are higher for women. CMS expenditures on women with CVD are $34 billion (Table 2).
  
1 Cardiovascular disease includes hypertension, coronary heart disease, cerebrovascular disease, and heart failure. 
2 CVD includes heart diseases, hypertensive disease, stroke, and heart failure (AHA, 2009).
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Prevention: 
	Primary care: Left under-treated or untreated, high blood pressure can lead to other serious health 
conditions such as heart disease, stroke, and kidney disease. Risk factors for hypertension include 
overweight and obesity, for which effective interventions are available. Weight loss, exercise, 
smoking cessation, alcohol reduction, salt restriction, dietary changes and stress reduction have 
all been shown effective in decreasing blood pressure (CDC, 2008a). 
	Pregnancy care: Blood pressure monitoring and management are essential parts of prenatal care. 
Death from maternal hypertensive disease is preventable through early diagnosis and blood 
pressure management. Identification of hypertension in pregnancy provides an opportunity to 
identify women at higher risk of heart disease later in life. 
Mental Health 
Prevalence: The importance of mental health disorders is often underestimated: close to half the 
adult population has a mental health disorder sometime in their lives, and 3.4 million adult women 
are estimated to have suffered from serious psychological distress in the previous 30 days (Kessler et 
al., 2005a).31During their lifetimes, women are 1.7 times more likely to suffer from major depressive 
disorder than men (Kessler et al., 2003) and 1.5 times more likely to suffer from lifetime mood disorder 
(Kessler et al., 2005a). In the majority of cases, depression goes unrecognized and untreated. The highest 
rates for depression occur in women between 25 and 44 (Weissman, 1995). An estimated 500,000 
pregnancies each year involve women with psychiatric illnesses that either predate or emerge during 
pregnancy (ACOG, 2008). Although pregnancy itself does not increase the risk of depression, symptoms 
are common in pregnancy. Approximately 10% to 16% of pregnant women fulfill diagnostic criteria for 
depression, and up to 70% of pregnant women report symptoms of depression (Nayak and Al-Yattama, 
1999). Many symptoms of depression overlap with the symptoms of pregnancy and are often overlooked 
(Gotlib, 1989).
Many medical conditions – including migraine, viral and bacterial infections, HIV/AIDS, cancer, and 
cardiopulmonary disease – are accompanied by symptoms of depression. In addition, depression 
frequently coexists with other medical conditions. 
Health disparities: Whites have a higher risk for reported lifetime mental disorder – including any 
anxiety, mood, and substance use disorder – than African-Americans (Kessler et al., 2005b). Conditions 
among African-American and Hispanic minorities may be underreported due to stigma, reduced access 
to services, and/or reluctance to seek medical care. 
  
3 Lifetime prevalence is defined as the number of people who have had a mental disorder sometime in their lifetime. The 
DSM-IV disorders include anxiety disorders (panic disorder, generalized anxiety disorder, agoraphobia without panic disor-
der, specific phobia, social phobia, post-traumatic stress disorder, obsessive-compulsive disorder, separation anxiety disorder), 
mood disorders (major depressive disorder, dysthymia, bipolar disorder I or II), impulse control disorders (oppositional defiant 
disorder, conduct disorder, attention-deficit/hyperactivity disorder, intermittent explosive disorder), and substance use disorders 
(alcohol and drug abuse and dependence).
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Costs: In 2007, annual total costs for mental health disorders (using the CMS definition) among men and 
women were $209 billion (2009 dollars) or 7.5% of total costs of treating illness in the United States 
(NHLBI, 2007). Based on the proportion of women suffering from a mental health disorder, direct costs 
associated with mental health disorders would be $84.7 billion. Indirect costs estimated on the basis of 
suicide-related costs and work-related costs outweigh direct medical costs for both men and women; 
respectively $70 billion and $32 billion (2009 dollars) (NHLBI, 2007). With the exception of coronary 
artery disease, depression results in more lost time from work than any other medical condition, with 
direct costs related to the illness estimated to be $20.2 billion (2009 dollars). CMS expenditures on 
women with depression are $4.4 billion in direct expenditures (Table 2).
Prevention: 
	Primary care: The two most common treatments for depression are psychotherapy and 
medication. The National Institute of Mental Health recommends psychotherapy for mild to 
moderate depression. Studies indicate that for adolescents a combination of medication and 
psychotherapy is the most effective treatment for major depression and reduces the likelihood 
of recurrence (March et al., 2004). Health promotion through self-care education is found to be 
highly effective to reduce substance abuse and improve mental health (Broskowski and Smith, 
2001). 
	Pregnancy care: Counseling and medication are available to women for a variety of psychiatric 
conditions in pregnancy and after delivery.  Ongoing treatment and monitoring are important to 
maintain the health of the women and infant.
Breast Cancer  
Prevalence: Breast cancer is the second leading cause of all cancer-related deaths among women, after 
lung cancer. The lifetime risk for a woman to develop breast cancer is approximately 13%, meaning that 
one in eight women develops breast cancer.
Health disparities: The incidence of breast cancer is higher among white women than among African-
American women. However, African-American women are more likely to die of the disease (32.8 per 
100,000 for African Americans and 23.3 per 100,000 for whites) (CDC, 2005a). Researchers have found 
that due to disparities in income and access to care, African-American women tend to be diagnosed at 
later stages of breast cancer than white women. (Hogue, 2002).
Costs: The National Cancer Institute estimates direct breast cancer treatment costs to be $9.1 billion 
(2009 dollars based on 1997-1999 prices) (NCI, 2008). Close to 100% of these costs are for women. 
Federal expenditures through the Medicare and Medicaid screening and diagnostic programs on 
women with breast cancer are $0.8 billion of direct expenditures (Table 2)(Moyer Table, available from 
HHS). Medicare and Medicaid also cover a significant portion of breast cancer treatment costs which are 
unreported by CMS.
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Prevention: 
	Primary care: Clinical breast exams, screening mammograms, and ultrasound imaging improve 
early detection of breast cancer. Some individuals with inherited forms of breast and ovarian 
cancer can have their risk identified with the help of genetic testing. Early detection of breast 
cancer has been shown to decrease the mortality rate (ACS, 2003). 
	Pregnancy care: Breast care is an important part of prenatal care, including breast exams at the 
beginning and end of pregnancy. Breastfeeding can reduce the risk of breast cancer, and studies 
have shown that counseling can be successful at promoting increased breastfeeding (Schwarz et 
al., 2009).
Cervical Cancer
Prevalence: In 2006, 1.4 million women over the age of 18 were told by a doctor or other health 
professional that they had cervical cancer (HHS, 2007). The American Cancer Society estimates that in 
2003, more than 13,000 new cases of invasive cervical cancer and 4,100 deaths from it occurred in 
the United States. Cervical cancer is the cancer most commonly diagnosed during pregnancy (ASCCP, 
2009). 
Health disparities: Survival rates vary among ethnic groups. For cervical cancer, both incidence and 
survival rates for African-American women are lower than those of white women (HHS, 2007). Death 
rates among black women (5.9 per 100,000) are approximately twice as high as among white women 
(2.4 per 100,000). The incidence of cervical cancer is highest among Vietnamese women (43.0 per 
1000,000) as compared to (11.2 per 100,000) for black and (7.3 per 100,000) for white women 
(CDC, 2000). The persistent disparity is attributed to the prevalence of risk factors for cervical cancer, 
differences in screening and treatment, and differences in stage of disease at diagnosis (CDC, 2000). 
Costs: In 2003, direct annual costs of treating cervical cancer were estimated at $340 million to $450 
million (2009 dollars) (Insinga et al., 2005). 
Prevention: 
	Primary care: Much of the substantial decrease in incidence of invasive cervical cancer 
and mortality from the disease is attributed to widespread use of Pap smear testing. Where 
comprehensive detection, treatment, and referral programs have been implemented, the 
incidence and mortality rates of this cancer have decreased dramatically (Sankaranarayanan 
et al, 2001). Most cases of invasive cervical cancer occur among women who were not 
screened during the previous five years (Grosse et al., 2007). One in 10 adult women are not 
regularly screened (Sirovich and Welch, 2004). The Human Papilloma Virus (HPV) vaccine is 
recommended for women age 26 and younger and helps prevent the most common forms of 
HPV that lead to cervical cancer.
	Pregnancy care: Cervical cancer screening is an essential component of prenatal care, with   
screening at the beginning and end of pregnancy. It is also recommended for preconception and   
interconception care. 
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Diabetes
Prevalence: Diabetes is the fifth-deadliest disease in the United States. Approximately 9 million or 7.7% 
of all adult women in the United States have diabetes (NHIS, 2007). However, about a third of them  
are not aware of their condition. A woman born in 2000 has an estimated 38.5% lifetime risk of 
developing diabetes (Narayan et al, 2003). Before women develop Type 2 diabetes, they usually 
have “pre-diabetes” – blood glucose levels that are higher than normal but not yet high enough to 
be diagnosed as diabetes. Some 57 million people in the U.S. have pre-diabetes (National Diabetes 
Clearinghouse, 2008). People with pre-diabetes may be able to prevent the development of Type 2 
diabetes by making dietary changes and increasing their physical activity levels, thereby reducing the 
potential for long-term damage to the body (ADA).
 
Women with diabetes are also at increased risk of vaginal infections and complications during 
pregnancy. Gestational diabetes, or diabetes that develops during pregnancy, occurs in 5% of all 
pregnancies, or about 200,000 cases a year (NICHD, 2009). Women who have had gestational diabetes 
are at increased risk for developing Type 2 diabetes later in life (Dornhorst and Rossi, 1998; Buchanan et 
al., 1998). 
People with diabetes are at increased risk for other diseases, including cardiovascular disease, the most 
common complication. The increased risk for CVD is more serious among women than men; deaths 
from heart disease in women with diabetes have increased by 23% over the past 30 years, compared to 
a 27% decrease in deaths from heart disease among women without diabetes (Gu et al., 1999). 
Health disparities: The prevalence of physician-diagnosed diabetes is two to four times higher among 
African-American, Hispanic/Latina, American Indian, and Asian/Pacific Islander women than among 
white women. 
Costs: In 2007, total estimated cost of diabetes among men and women was $178 billion (2009 dollars) 
with two-thirds spent on direct medical costs (Dall et al, 2008). Direct diabetes costs in 2007 for women 
totaled close to $60 billion (2009 dollars) (Table 2). In 2009, CMS estimates $4.8 billion in spending for 
treatment of diabetes in women.  
Prevention: 
	Primary care: Regular screening for glucose levels, hypertension, and weight loss and exercise 
counseling in physicians’ offices have been effective at preventing the progression of pre-diabetes 
to diabetes. 
	Pregnancy care: Diabetes in pregnancy must be found early or even prior to pregnancy to 
significantly improve outcomes. Identification of risk factors and diagnosis of gestational diabetes 
provides an opportunity to address and reduce the later risks for Type 2 diabetes and heart disease 
in women.
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Osteoporosis 
Prevalence: In 2002, 7.8 million postmenopausal women, or one in five women over the age of 50, had 
osteoporosis. Another 21.8 million had low bone mass and thus were at increased risk for osteoporosis 
(National Osteoporosis Foundation, 2002). Osteoporosis results in over 2 million fractures every year in 
the U.S., with close to 1.5 million of them experienced by women (Burge et al., 2007). 
Health disparities: In 2005, the overwhelming majority of fractures (88.6%) occurred among non-
Hispanic white women (Burge et al., 2007). 
Costs: In 2005, direct medical costs due to osteoporosis-related fractures were estimated to total $13.9 
billion for women (2009 dollars) (Burge et al., 2007). The majority (72%) of these costs were related to 
hip fractures, (Burge et al., 2007). Fractures become more frequent with age and are expensive to treat. 
Aging and other demographic trends will increase future prevalence and incidence of osteoporosis-
related fractures. As a result, direct medical expenditures are projected to grow by almost 50% by 2025, 
to $25 billion per year (Burge et al., 2007). 
Prevention: 
	Primary care: Osteoporosis is a largely preventable complication of aging. Appropriate screening 
strategies and significant pharmacologic interventions are available to prevent and treat 
osteoporosis. Women should be counseled about preventive measures early in life: adequate 
calcium consumption; using dietary supplements if dietary sources are not adequate; adequate 
vitamin D consumption; regular weight-bearing and muscle-strengthening exercises to reduce 
falls and prevent fractures; smoking cessation; and moderation of alcohol consumption. 
	Pregnancy care: Prenatal vitamins taken throughout a pregnancy and even in preparation for a 




Prevalence: Annually, intimate partner violence (IPV)41results in approximately 2 million injuries and 
1,300 deaths for women. In 2005, a set of questions related to IPV was administered with the Behavioral 
Risk Factor Surveillance System (BRFSS) in 16 states. Results suggest that one in every four women in the 
study experienced IPV in her lifetime (Breiding, Black, Ryan, 2008a). Women who are victims of IPV are 
more likely to have worse health outcomes such as high cholesterol, CVD, joint disease, asthma, and 
activity limitations. In addition, they are more likely to adopt unhealthy behaviors such as risk factors 
for HIV infection, smoke, or drink, and are less likely to visit a doctor for check-ups (Breiding, Black, 
Ryan, 2008b). Women who have a history of IPV may also be more likely to become involved with the 
criminal justice system (Covington, 2007).
 
4 IPV against women includes rape, physical assault, and stalking perpetrated by a current or former date, boyfriend, husband, 
or cohabiting partner, with cohabiting meaning living together as a couple (Breiding, Black, Ryan, 2008a).
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Health disparities: Reported lifetime IPV was higher among women of more than one ethnic origin 
than non-Hispanic white women, while Asian and Hispanic women were less likely to report intimate 
partner violence than non-Hispanic white women (Breiding, Black, Ryan, 2008a). A separate nationally 
representative survey by the National Crime Victimization Survey showed that the percentage of nonfatal 
IPV51reported to the police between 2001 and 2005 was higher among African-American females than 
white females (Catalano, 2007). 
Costs: In 2003, total direct medical costs related to IPV were estimated to be $6.7 billion (2009 dollars) 




	Primary care: Many professional societies continue to recommend screening or assessing patients 
for IPV (Lipsky et al., 2009). Both primary and secondary prevention efforts should be culturally 
informed and specific. Racial/ethnic groups are complex, heterogeneous, and diverse and may 
benefit from tailored prevention efforts. 
	Pregnancy care: Women should be screened regularly at prenatal and postpartum visits. 
Pregnancy is one of the few times when women and their partners are present for care; thus it is 
an important opportunity for violence screening. 
Sexually Transmitted Infections 
Prevalence: 19 million new sexually transmitted infections (STIs)62occur each year in the United States 
— almost half of them among young people 15 to 24 years of age. One in four American teens has 
an STI. In 2007, 1,108,374 cases of Chlamydia trachomatis were reported to the Centers for Disease 
Control and Prevention (CDC). This is the highest number of cases ever reported to CDC for any 
condition. Each year, 2.2 million pregnant U.S. women are infected with an STI (CDC, 2008b). The 
majority suffer from bacterial vaginosis (1 million), a condition where the normal balance of bacteria in 
the vagina is disrupted, and herpes simplex virus 2 (0.8 million).
Women bear a disproportionate burden of the long-term health consequences of STIs, including pelvic 
inflammatory disease and infertility. In 2007, the rate of Chlamydia cases among women was three times 
that of men (543.6 cases per 100,000 women compared to 190 cases per 100,000 men). The gonorrhea 
infection rate was also higher among women (123.5 per 100,000 women compared to 113.7 per 
100,000 among men). 
Impact on chronic disease: Human Papilloma Virus (HPV) infection is the cause of almost all cervical 
cancers (Steben and Duarte-Franco, 2007). Chlamydia and gonorrhea often have no symptoms and 
may go undetected. If left untreated, up to 40% of Chlamydia and gonorrhea infections in women can 
cause ectopic pregnancy, chronic pelvic pain, or result in pelvic inflammatory disease – a condition that 
causes as many as 50,000 women to become infertile each year.
5 IPV in the NCVS is defined as ‘rape, sexual assault, robbery, aggravated assault, and simple assault’.
6 STIs includes HIV, HPV, genital herpes, hepatitis B, Chlamydia, gonorrhea, trichomoniasis, and syphilis.
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Health disparities: Across all age groups, non-Hispanic African-American women have the highest rate 
of Chlamydia, followed by American Indian/Alaskan Native and Hispanic women. In 2007, gonorrhea 
rates were 19 times higher among African-Americans than among whites. 
Costs: The estimated lifetime direct medical costs of nine million new cases of STIs among 15- to 
24-year-olds (men and women) in 2000 was $4.3 billion (2009 dollars) (Chesson et al., 2004). Given 
an average life expectancy of 78 years (75 years for men and 80 years for women), approximately $70 
million (2009 dollars) annually is spent on STIs excluding HIV. The lifetime costs per case of HPV, 
Chlamydia, and gonorrhea are more for women than for men. HPV is the most costly STI (not including 
HIV/AIDS), accounting for $3.6 billion (2009 dollars) in lifetime direct medical costs (Chesson et al., 
2004).
Prevention: 
	Primary care: Most women are infected through unprotectected heterosexual contact. Annual 
Chlamydia screening for all sexually active women under age 26 is recommended, as well as for 
older women with risk factors such as new or multiple sex partners. Vaccines are available for the 
prevention of two common sexually transmitted viral infections: Hepatitis B and HPV. Abstinence 
and reduction in the number of sexual partners can be effective methods of avoiding STIs. Latex 
condoms, when used consistently and correctly, can reduce the risk of gonorrhea, Chlamydia, 
and trichomoniasis transmission. 
	Pregnancy: The 2006 CDC Guidelines for Treatment of Sexually Transmitted Diseases (STDs) 
recommend that pregnant women be screened on their first prenatal visit for STDs including 
Chlamydia, gonorrhea, hepatitis B, HIV, and syphilis. 
HIV/AIDS
Prevalence: In 2005, a total of 126,964 women were living with diagnosed HIV/AIDS (CDC, 2008c). In 
2005 an additional 9,708 women were newly diagnosed (CDC, 2008c). Although the number of new 
cases declines annually, women accounted for 27% of HIV cases in 2004, up from 8% in 1985 (KFF, 
2006). Over 50% of HIV/AIDS cases are estimated to be undiagnosed. CDC estimated that by the end of 
2006, approximately 278,400 adult and adolescent women were living with diagnosed or undiagnosed 
HIV/AIDS (CDC, 2008c). 
Women can transmit HIV to their children during pregnancy, during delivery, or through breastfeeding. 
Nearly all AIDS cases among U.S. children are due to mother-to-child transmission. In 1992, 855 U.S. 
children developed AIDS, but in 2005 only 57 children developed AIDS (CDC, 2008c) due to increased 
screening of pregnant women and increased administration of antiretroviral medication to prevent 
vertical transmission of HIV during childbirth.
Impact on chronic disease: People living with HIV who are not treated will probably develop one or 
more opportunistic infections such as pneumocystis carinii pneumonia, candidiasis, toxoplasmosis, 
cytomegalovirus retinitis, tuberculosis, and increased risks of cervical cancer, and lymphomas (DHHS, 
2009). Untreated HIV, of course, most often leads to a diagnosis of AIDS.
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Health disparities: African-American and Hispanic women are at significantly higher risk of contracting 
HIV/AIDS. In 2007, the incidence among female adults and adolescents was nearly 20 times as 
high among African-American women (60.6 per 100,000) as the rate among white females (3.3 per 
100,000), and the incidence among Hispanic females was nearly four times as high (16 per 100,000) 
(CDC, 2008c). In 2007, the AIDS diagnosis rate was 22 times higher for African-American females than 
for white females, 39.8 and 1.9 per 100,000 respectively (CDC, 2008c). In 2007, the estimated HIV 
prevalence rate for African-American women (1,122.4 per 100,000) was nearly 18 times the rate for 
white women (62.7 per 100,000), and the rate for Hispanic women (263.0 per 100,000) was more than 
four times the rate for white women (CDC, 2008d). HIV is the leading cause of death among African-
American women between 25 and 34 (CDC, 2008c). 
Costs: Lifetime HIV costs per new case range between $176,500 and $223,300. HIV accounts for 
$3.3 billion to $4.1 billion (2009 dollars) in direct lifetime medical costs for both men and women, 
or between $272 million and $344 million in annual direct costs (Chesson et al., 2004). Chesson et 
al. estimated a lower bound of expenditures because their lifetime costs are based on 12 years of care 
while estimated life expectancy following HIV infection is 22 to 26 years for persons receiving highly 
active antiretroviral treatment (HAART). Using the share of HIV cases affecting women (27%), lifetime 
direct costs accounts for between $0.9 billion and $1.1 billion or between $73 million and $93 million 
annually. 
Prevention: 
	Primary care: The CDC recommends HIV testing be a routine part of medical care. Abstinence 
and reduction in the number of sexual partners can be effective methods of avoiding STIs. 
Latex condoms, when used consistently and correctly, are highly effective in preventing HIV 
transmission. 
	Pregnancy: The 2006 CDC Guidelines for Treatment of Sexually Transmitted Diseases recommend 
that pregnant women be screened on their first prenatal visit for HIV. Women who have HIV 
can reduce the likelihood that their child will contract HIV during pregnancy from 25% to 2% 
if certain precautions are taken. These include: seeing a medical professional, taking prescribed 
medications (e.g., AZT), and arriving at the hospital early for delivery.
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Health Behaviors and Risks:
Smoking 
Prevalence: Smoking prevalence among women has decreased substantially since the 1960s, but one in 
six adult women over the age of 18 (17.4%) still smoked in 2007 (NHIS, 2007). Cigarette smoking during 
pregnancy is the most modifiable cause of adverse birth outcomes in the U.S. Despite extensive anti-
smoking publicity, an estimated 11% to 20% of all pregnant women in the U.S. still smoke (Jesse et al., 
2005). 
Impact on mortality: Cigarette smoking continues to cause premature deaths: between 1995 and 1999, 
an average of 178,311 deaths among women annually (CDC, 2002). Cigarette smoking accounts for 30% 
of all cancer deaths in the U.S., including one in four lung cancer deaths, and is highly related to heart 
disease and chronic lung disease (Jemal et al., 2008; CDC, 2005b). Smoking during pregnancy, even light 
smoking (less than six cigarettes per day), has negative consequences such as reduced birth weight and up 
to 40% higher infant mortality (Martin et al., 2003). Cigarette smoking also increases the risk for stillbirth 
and sudden infant death syndrome (CDC, 2006). 
Impact on chronic diseases: Smoking increases risk for cancers, including stomach and cervical cancer. 
Women who smoke double their risk for developing coronary artery disease and increase by more than 
tenfold their likelihood of dying from chronic obstructive pulmonary disease. Postmenopausal women 
who smoke have lower bone density and increased risk for hip fractures than women who never smoked 
(DHHS, 2001). Cigarette smoking is one of the most important modifiable causes of poor reproductive 
health and pregnancy outcomes in the United States - it increases the risk for infertility, preterm delivery, 
and low birth weight. 
Health disparities: Current smoking rates among racial/ethnic groups vary widely. One in four American 
Indian or Alaska Native women currently smokes cigarettes (26.8%), significantly more than among 
white women (20%) and African American women (17.3%). Smoking among Hispanics and Asians is 
significantly lower, 11% and 6% respectively (CDC, 2006). 
Costs: Estimated direct costs of smoking range between 6% and 8% of total annual expenditures for health 
care (Surgeon General, 2004). In 1995 and 1999, smoking tobacco resulted in a total estimated cost of 
$200 billion (2009 dollars) with close to half spent on direct medical costs (CDC, 2002). Direct costs 
the proportion of smokers who are women totaled around $46 billion (2009 dollars) for women and an 
additional $34 billion (2009 dollars) in productivity costs (CDC, 2002). Every $1.00 spent on targeted 
smoking cessation counseling among pregnant women was found to result in $3.31 savings in subsequent 
direct costs for low-birth-weight infants in a neonatal intensive care unit (Broskowski and Smith, 2001).
Prevention: 
	Primary care: Tobacco smoking prevention and control is one of the most cost-effective forms 
of health promotion (Grosse et al., 2007). Comprehensive state-level tobacco control programs 
that included both mass media campaigns and telephone quit lines have been highly successful 
at low cost to reduce overall smoking and the prevalence of youth smoking (Grosse et al., 2007). 
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	Pregnancy Care: Increased public education measures and public health campaigns in the 
United States have led to a decline in smoking during pregnancy (Colman and Joyce, 2003). 
Pregnancy motivates women to make lifestyle changes; approximately 46% of pre-pregnancy 
smokers quit during pregnancy. It is estimated that eliminating smoking during pregnancy 
would reduce infant deaths by 5% and reduce the incidence of singleton low-birth-weight 
infants by 10.4% (Salihu et al., 2003; Ventura, 2003).
Obesity
Prevalence: The prevalence of obesity in the United States has increased dramatically over the past 13 
years. As a consequence, more than half the adult female population is overweight; one in four adult 
women in the U.S. is obese (25.6%) (BRFSS 2008). The prevalence of overweight and obesity among 
children and adolescents increased significantly between 1999 and 2004 (Ogden et al., 2006). 
Impact on chronic disease: Obesity is a major risk factor for many chronic diseases and associated with 
increased health problems, including Type 2 diabetes, hypertension, cardiovascular diseases, infertility, 
heart disease, gallbladder disease, osteoarthritis, gynecological problems such as abnormal menses 
and infertility, and a variety of cancers, including breast, uterine, and colon cancers (CDC, 2009). In 
addition, obese women are five times more likely than non-obese women to develop endometrial 
cancer.
Health disparities: Obesity is more prevalent among African-American and Hispanic women and varies 
by race and ethnicity. Between 2001 and 2004, 51% of African-American adult women were obese, 
compared with 39% of women of Hispanic origin and 31% of non-Hispanic white women (NCHS, 
2007). Health disparities start at a young age; African-American and Hispanic girls are more likely to be 
obese than non-Hispanic white girls in grades 9-12 (AHA, 2009). 
Costs: There is a clear relationship between obesity and increasing health care costs. Obese people have 
36% higher inpatient costs and 77% higher medication costs than non-obese people (Sturm, 2002). 
Twenty-seven percent of the rise in health care expenditures in the U.S. relative to other developed 
countries is attributed to obesity (Thorpe et al., 2004). In 1998, overweight- and obesity-attributable 
medical spending represented almost 10 percent of health care spending in the U.S., a total of $114 
billion (2009 dollars) (Finkelstein et al., 2003). Direct costs of obesity, based on the share of obese 
women, totaled around $57 billion (2009 dollars). Incremental lifetime costs of obesity for the 9 million 
obese children in the U.S. would account for almost $500 billion (McKinnon, 2009). 
Prevention: 
	Primary Care 
Primary Prevention: Exercise and good nutrition are critical to maintaining a healthy weight. 
The Surgeon General recommends physical activity for adults of at least 30 minutes on most 
days of the week, and 60 minutes on most days of the week for children. Recommendations 
also include consuming nutrient-dense foods and beverages while limiting intake of saturated 
and trans-fats, cholesterol, added sugars, salt, and alcohol.
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Secondary prevention: The U.S. Preventive Services Task Force recommends that clinicians 
screen all adult patients for obesity and offer counseling and behavioral interventions to 
promote sustained weight loss for obese adults. Nutrition and weight loss counseling have 
been shown to be effective at weight reduction in a primary care setting. Physical activity 
and nutrition habits are teachable and modifiable. In addition, according to NIH’s National 
Heart, Lung, and Blood Institute, losing as little as 5% to 10% of one’s base weight leads to 
significant reductions in risks for development of heart disease, diabetes, and high blood 
pressure.
	Pregnancy care: The prevention of maternal obesity and maternal diabetes is critically 
important. Maternal obesity and diabetes are linked to increased birth weight and consequent 
increased body weight in adulthood (Whitaker and Dietz, 1998). There is a clear association 
between birth weight and adult weight. Therefore, it is important to ensure only appropriate 
weight gain as specified by a healthcare provider. A moderate weight reduction is safe for 
breastfeeding women and does not compromise weight gain of the nursing infant (DHHS, 
2005). 
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Conclusion
This report demonstrates the extremely high costs of chronic conditions and illnesses in women and 
the disproportionate burden of disease and disability they face. However, calculating the true costs of 
chronic diseases and conditions is difficult, as is measuring the direct or indirect saving that may accrue 
through high quality primary and preventive care. Estimated costs to Medicare and Medicaid are limited 
by the reporting by specific disease category and likely underestimate the costs to CMS.  
The recommendations for early primary care and preventive services during the reproductive years 
identify key opportunities to reduce the impact of chronic illness later in life through prevention, early 
detection and early intervention. Screening for cancer, risks for heart disease, family planning services 
and detection of violence, as well as smoking cessation and nutrition counseling, should begin early 
in life and continue through a woman’s reproductive years during primary care and family planning 
visits. Identification of hypertension and/or gestational diabetes in pregnancy provides an opportunity 
to identify women at higher risk of heart disease and diabetes later in life, along with the possibility of 
reducing her risks and improving her health outcomes as she ages.
These findings make it clear that in order to improve the long-term health of women and to reduce the 
burden of chronic disease and conditions, health care reform should ensure that: 
	Comprehensive primary care and reproductive health care – and access to early prevention, 
detection and appropriate treatment – are available to all women; 
	Health care for pregnant women begins prior to pregnancy, including help with the timing 
and spacing of pregnancies; and 
	Women’s health care is comprehensive and continuous across the lifespan.
 
Consistent with the earlier report Women’s Heath and Health Care Reform: The Key Role of 
Comprehensive Reproductive Health Care, health care reform must therefore achieve three core goals:
1) Health insurance coverage must make care available, affordable and stable at the right time 
and in the right place; 
2) Direct investments should be made in infrastructure and a qualified workforce; and 
3) Public health investments should be made in community health promotion and surveillance.
In addition, a well-woman standard of care, providing access to essential health care services and 
established through the reform of our health care system, would ensure that women attain good health 
in childhood and adolescence, maintain good health during their reproductive years and age well.
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